Medications critical for treating patients with COVID-19, such as propofol, morphine and epinephrine, are in short supply, prompting recommendations for stricter measures to reduce medication waste from the American Society of Anesthesiologists (ASA) and the American Society of Health-System Pharmacists (ASHP).
Other drugs that are currently in shortage include dexmedetomidine, atropine, fentanyl, ketamine, hydromorphone, cisatracurium, dopamine and dobutamine. These drugs are included on the